JP2024543134A5 - - Google Patents
Info
- Publication number
- JP2024543134A5 JP2024543134A5 JP2024531051A JP2024531051A JP2024543134A5 JP 2024543134 A5 JP2024543134 A5 JP 2024543134A5 JP 2024531051 A JP2024531051 A JP 2024531051A JP 2024531051 A JP2024531051 A JP 2024531051A JP 2024543134 A5 JP2024543134 A5 JP 2024543134A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- monovariate
- immunoglobulin
- modified immunoglobulin
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111429892.3 | 2021-11-29 | ||
| CN202111429892 | 2021-11-29 | ||
| PCT/CN2022/134923 WO2023093899A1 (zh) | 2021-11-29 | 2022-11-29 | 经修饰的蛋白或多肽 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543134A JP2024543134A (ja) | 2024-11-19 |
| JP2024543134A5 true JP2024543134A5 (cg-RX-API-DMAC7.html) | 2026-03-27 |
Family
ID=86538884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531051A Pending JP2024543134A (ja) | 2021-11-29 | 2022-11-29 | 修飾されたタンパク質又はポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250026842A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4435002A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024543134A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118339179A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202330596A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023093899A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024114676A1 (zh) | 2022-11-29 | 2024-06-06 | 江苏恒瑞医药股份有限公司 | Cldn18.2/4-1bb结合蛋白及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| SG10201805064SA (en) * | 2011-06-23 | 2018-07-30 | Ablynx Nv | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| RS55775B2 (sr) * | 2011-06-23 | 2022-10-31 | Ablynx Nv | Tehnike za predviđanje, otkrivanje i smanjenje nespecifične proteinske interferencije u testovima koji uključuju pojedinačne varijabilne domene imunoglobulina |
| PE20141522A1 (es) | 2011-08-17 | 2014-11-17 | Glaxo Group Ltd | Proteinas y peptidos modificados |
| AU2013258834B2 (en) * | 2012-05-10 | 2017-09-07 | Zymeworks Bc Inc. | Heteromultimer constructs of immunoglobulin heavy chains with mutations in the Fc domain |
| WO2014111550A1 (en) * | 2013-01-17 | 2014-07-24 | Glaxosmithkline Intellectual Property Development Limited | Modified anti-serum albumin binding proteins |
| EP4707303A2 (en) * | 2014-05-16 | 2026-03-11 | Ablynx NV | Improved immunoglobulin variable domains |
| JP7001474B2 (ja) * | 2015-01-21 | 2022-01-19 | インヒブルクス，インコーポレイティド | 非免疫原性単一ドメイン抗体 |
| NO2768984T3 (cg-RX-API-DMAC7.html) * | 2015-11-12 | 2018-06-09 | ||
| CN113621065B (zh) * | 2021-08-30 | 2023-08-01 | 武汉海沙百得生物技术有限公司 | 靶向4-1bb的全人源抗体及其制备方法和应用 |
-
2022
- 2022-11-29 US US18/713,577 patent/US20250026842A1/en active Pending
- 2022-11-29 TW TW111145700A patent/TW202330596A/zh unknown
- 2022-11-29 JP JP2024531051A patent/JP2024543134A/ja active Pending
- 2022-11-29 EP EP22897980.3A patent/EP4435002A4/en active Pending
- 2022-11-29 CN CN202280075005.3A patent/CN118339179A/zh active Pending
- 2022-11-29 WO PCT/CN2022/134923 patent/WO2023093899A1/zh not_active Ceased